Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siying Peng

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Cancers|October 14, 2022
Using Patient-Derived Xenograft (PDX) Models as a 'Black Box' to Identify More Applicable Patients for ADP-Ribose Polymerase Inhibitor (PARPi) Treatment in Ovarian Cancer: Searching for Novel Molecular and Clinical Biomarkers and Performing a Prospective Preclinical TrialJiayu Chen, Yan Li, Haiyuan Wang, et al.
The Journal of Physical Chemistry Letters|August 12, 2022
Optical Visualization of Photoexcitation Diffusion in All-Inorganic Perovskite at High TemperatureXiao-Ze Li, Nuerbiya Aihemaiti, Hong-Hua Fang, et al.
Journal of the National Cancer Center|July 22, 2024
Head-to-head comparison of 7 high-sensitive human papillomavirus nucleic acid detection technologies with the SPF10 LiPA-25 systemJian Yin, Shuqian Cheng, Daokuan Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 9, 2022
Large-cohort humanized NPI mice reconstituted with CD34<sup>+</sup> hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapyXiongfei Xu, Haihui Gu, Hongwei Li, et al.
Stem Cell Reports|March 28, 2014
Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogrammingGengzhen Zhu, Yujing Li, Fei Zhu, et al.
Frontiers in Oncology|October 21, 2021
Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian CancerJiayu Chen, Ying Jin, Siyi Li, et al.
Emerging Microbes & Infections|March 6, 2023
Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trialGuohua Zhong, Chunlan Zhuang, Xiaowen Hu, et al.
European Journal of Medicinal Chemistry|October 9, 2024
Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasisGang Li, Dengqin He, Xudong Qian, et al.
Genes & Development|November 9, 2019
Context-specific regulation of cell survival by a miRNA-controlled BIM rheostatVerena Labi, Siying Peng, Filippos Klironomos, et al.
BMC Public Health|September 28, 2023
The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance studyLingxian Qiu, Sheng Liu, Minglei Zhang, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cancers|October 14, 2022
Using Patient-Derived Xenograft (PDX) Models as a 'Black Box' to Identify More Applicable Patients for ADP-Ribose Polymerase Inhibitor (PARPi) Treatment in Ovarian Cancer: Searching for Novel Molecular and Clinical Biomarkers and Performing a Prospective Preclinical TrialJiayu Chen, Yan Li, Haiyuan Wang, et al.
The Journal of Physical Chemistry Letters|August 12, 2022
Optical Visualization of Photoexcitation Diffusion in All-Inorganic Perovskite at High TemperatureXiao-Ze Li, Nuerbiya Aihemaiti, Hong-Hua Fang, et al.
Journal of the National Cancer Center|July 22, 2024
Head-to-head comparison of 7 high-sensitive human papillomavirus nucleic acid detection technologies with the SPF10 LiPA-25 systemJian Yin, Shuqian Cheng, Daokuan Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 9, 2022
Large-cohort humanized NPI mice reconstituted with CD34<sup>+</sup> hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapyXiongfei Xu, Haihui Gu, Hongwei Li, et al.
Stem Cell Reports|March 28, 2014
Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogrammingGengzhen Zhu, Yujing Li, Fei Zhu, et al.
Frontiers in Oncology|October 21, 2021
Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian CancerJiayu Chen, Ying Jin, Siyi Li, et al.
Emerging Microbes & Infections|March 6, 2023
Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trialGuohua Zhong, Chunlan Zhuang, Xiaowen Hu, et al.
European Journal of Medicinal Chemistry|October 9, 2024
Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasisGang Li, Dengqin He, Xudong Qian, et al.
Genes & Development|November 9, 2019
Context-specific regulation of cell survival by a miRNA-controlled BIM rheostatVerena Labi, Siying Peng, Filippos Klironomos, et al.
BMC Public Health|September 28, 2023
The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance studyLingxian Qiu, Sheng Liu, Minglei Zhang, et al.
Pageof 5